Predictive value of the cardiogenic shock working group-modified SCAI criteria in early-stage heart failure-related

Tijmen H Ris1, Morsal Atazadah1, Roel Hoek1

  • 1Department of Cardiology, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands.

Insights

The Cardiogenic Shock Working Group-modified Society for Cardiovascular Angiography and Interventions (CSWG-SCAI) stage at diagnosis did not predict mortality in early heart failure with cardiogenic shock (HF-CS). However, CSWG-SCAI at 24 hours, 48 hours, and maximum stage predicted mortality, with minimal improvement from adding urine output.

Area of Science:

  • Cardiology
  • Critical Care Medicine

Background:

  • The Cardiogenic Shock Working Group-modified Society for Cardiovascular Angiography and Interventions (CSWG-SCAI) staging system is validated for cardiogenic shock (CS).
  • Its prognostic utility in early-stage heart failure with cardiogenic shock (HF-CS) remains under-investigated.

Purpose of the Study:

  • To assess the prognostic value of the CSWG-SCAI staging system in patients with early-stage HF-CS.
  • To evaluate the added predictive value of urine output (UO) to the CSWG-SCAI classification.

Main Methods:

  • A cohort of 208 patients with HF-CS was analyzed.
  • The relationship between CSWG-SCAI stages (at diagnosis, 24h, 48h, maximum) and in-hospital mortality was examined.
  • The incremental predictive value of incorporating UO into the CSWG-SCAI (SCAI-UO) was evaluated.

Main Results:

  • At diagnosis, CSWG-SCAI stages A and B were most prevalent; stage C dominated later.
  • In-hospital mortality was 42%.
  • CSWG-SCAI at diagnosis showed no prognostic value (p=0.994), but was associated with mortality at 24h (p=0.005), 48h (p=0.005), and maximum stage (p<0.001). Stage deterioration after 24h predicted mortality (p<0.001). SCAI-UO offered modest additive value at 48h (AUC 0.70 vs 0.67) and maximum stage (AUC 0.69 vs 0.66).

Conclusions:

  • The CSWG-SCAI classification at HF-CS diagnosis may not adequately predict in-hospital mortality in early stages.
  • The CSWG-SCAI staging system becomes prognostic at 24h, 48h, and maximum stage.
  • Integrating UO into CSWG-SCAI provides minimal improvement in risk stratification.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52